RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDYOFA NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS

被引：0
|
作者：
Yazici, Y. [1 ]
McAlindon, T. [2 ]
Gibofsky, A. [3 ,4 ]
Lane, N. [5 ]
Clauw, D. [6 ]
Grifman, M.
Swearingen, C. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. [1 ]
Hochberg, M. [7 ]
机构：
[1] Samumed LLC, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Weill Cornell Med, New York, NY USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Davis, CA 95616 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
432
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [1] RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Clauw, D. J.
    Jones, M. H.
    Bergfeld, J.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S293 - S294
  • [2] Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for the Treatment of Knee Osteoarthritis
    Yazici, Yusuf
    McAlindon, Timothy E.
    Gibofsky, Allan
    Lane, Nancy E.
    Clauw, Daniel J.
    Armas, Eddie
    Skrepnik, Nebojsa
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeymi
    Hochberg, Marc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 "Pain on Walking" - Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
    Tambiah, Jeyanesh
    Kennedy, Sarah
    Ghandehari, Heli
    Swearingen, Christopher
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] RESULTS FROM A 52 WEEK RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, WNT PATHWAY INHIBITOR (SM04690) FOR KNEE OSTEOARTHRITIS TREATMENT
    Yazici, Y.
    McAlindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Swearingen, C.
    DiFrancesco, A.
    Tambiah, J.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1146 - 1147
  • [5] Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
    Swearingen, Christopher J.
    Majumdar, Sharmila
    Simsek, Ismail
    DiFrancesco, Anita
    Tambiah, Jeymi
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR
    Kennedy, S.
    Ghandehari, H.
    Swearingen, C.
    Tambiah, J.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 81 - 82
  • [7] RADIOGRAPHIC OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 121 - 121
  • [8] CLINICAL OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    McAlindon, T. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 985 - 986
  • [9] RESULTS FROM A 52-WEEK, PHASE 2A STUDY OF AN INTRA- ARTICULAR, WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S51 - S52
  • [10] Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis
    Strand, Vibeke
    Ghandehari, Heli
    Swearingen, Christopher
    Tambiah, Jeyanesh
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345